Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

By Xiaofeng Liang, Shengli Bi, Weizhong Yang, Longde Wang, Gang Cui, F. Cui, Yong Zhang, Jianhua Liu, X. Gong, Yuan-sheng Chen and 12 more. Vaccine, 2009

903 citations recorded by the source corpus.

Subfields: Epidemiology, Health, Hepatology

View Paper: https://www.semanticscholar.org/paper/10bdbafb49045d867bac355b4b372e12e8d51b9f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. M. Kudo

In Hepatology

1. M. Kudo
2. A. Cheng

Citations in the corpus

• Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020 (2021, background): “The infant routine immunization against hepatitis B virus (HBV) in China since 1992 might be one of the main reasons for the decline in the incidence of liver cancer [41].”
• Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update (2017, background): “96% in 2006 in Mainland China, where universal infant HBV vaccination started in 1992 [125].”
• Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update (2015, neutral): “96 % in 2006 [11].”